IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer

1. Mayo, J.C.
2. Hevia, D.
3. Quiros-Gonzalez, I.
4. Rodriguez-Garcia, A.
5. Gonzalez-Menendez, P.
6. Cepas, V.
7. Gonzalez-Pola, I.
8. Sainz, R.M.